Health Catalyst, Inc. (HCAT) financial statements and ratios from SEC XBRL: revenue $311.14M (TTM), net margin -57.2%, revenue growth -12.7% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $311.14M |
| Net Margin | -57.2% |
| Revenue Growth (YoY) | -12.7% |
| EPS Growth (YoY) | -6.8% |
| FCF Growth (YoY) | -99.2% |
| Price / Book | 1.22 |
| Price / Sales | 0.42 |
| FCF Yield | 22.0% |
| Altman Z-Score | -3.77 (distress) |
| Sector P/E (Technology) | 33.9 |
HCAT overview · HCAT earnings · HCAT KPIs · HCAT investor relations · HCAT ownership · HCAT peers · HCAT filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.